Home > Drug Search >
  • company_query: Bio-Cancer Treatment International
  •   > 
Drug Filter
Category:
chemistry (6) biology (14)
Status:
BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (13) Phase Ⅰ (4)
Clinical Stage:
Pending (2) Active (16) Discontinued (2)
Bio-Type:
Gene therapy (3) Vaccine (3) Recombinant enzyme (1) Recombinant polypeptide (1) Recombinant cytokines (1) Fusion protein (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (2) Anemia (1) Atherosclerosis (1) Cutaneous T cell lymphoma (CTCL) (1) Duchenne muscular dystrophy (DMD) (1) Cytomegalovirus infections (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) Ischaemia (1) Melanoma (1) Osteoarthritis (OA) (1) Osteoporosis (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Hypoalphalipoproteinaemia (1) Lipid metabolism disorders (1) Seasonal allergic rhinitis (1) Acute intermittent porphyria (1) Head and neck cancer (1) Colorectal cancer (1) Sickle cell disease (1) Renal carcinoma (1) Sporadic inclusion body myositis (sIBM) (1) Glioblastoma (1) Acute kidney injury (1) Thelassemia (1) Cardiac reperfusion injury (1) Scleroderma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top